Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer
<p>Abstract</p> <p>Background</p> <p>The transcription factor activator protein-1 (AP-1) has been implicated in a large variety of biological processes including oncogenic transformation. The tyrosine kinases of the epidermal growth factor receptor (EGFR) constitute the...
Main Authors: | Hanson Bonnie J, Raha Debasish, O'Grady Michael, Bunting Michaeline, Hanson George T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/5/125 |
Similar Items
-
Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia.
by: Yunyi Kang, et al.
Published: (2015-01-01) -
Establishing an in vivo assay system to identify components involved in environmental RNA interference in the western corn rootworm.
by: Keita Miyata, et al.
Published: (2014-01-01) -
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
by: Chen Gang, et al.
Published: (2012-03-01) -
Nuclear outsourcing of RNA interference components to human mitochondria.
by: Simonetta Bandiera, et al.
Published: (2011-01-01) -
CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment.
by: Yasmine Even, et al.
Published: (2016-01-01)